加载中
HKSEHealthcareMedical - Care Facilities
最新数据
HK$9.61
+HK$0.12 · +1.26%
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.
最新数据
HK$9.61
+HK$0.12 · +1.26%
盘中时间采用HKT。市场数据可能有所延迟。
Hygeia Healthcare Holdings Co., Limited (6078.HK) is a prominent oncology healthcare provider primarily operating across the People's Republic of China. The company owns and manages a network of private, for-profit hospitals specializing in comprehensive cancer care. These facilities offer a broad spectrum of services, including diagnostic procedures such as tumor screening and genetic analysis, advanced therapeutic interventions like radiotherapy, surgery, chemotherapy, immunotherapy, and targeted treatments, alongside crucial supportive care including oncology rehabilitation, nutritional guidance, and hospice services. Beyond direct patient care, Hygeia also provides consulting expertise for radiotherapy centers and licenses its specialized SRT (Stereotactic Radiotherapy) equipment, offering ongoing maintenance and technical support for these systems. The company's operations extend to providing hospital and corporate management services, as well as supply chain solutions. By the end of 2021, Hygeia Healthcare had established a significant presence, operating or managing 12 oncology-focused hospitals spread across 9 cities in 7 provinces throughout mainland China. Established in 2009, the company maintains its headquarters in Shanghai, PRC.
日内区间
当前HK$9.61
52周区间
当前HK$9.61
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（CNY） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 40.09亿 CNY | 44.46亿 CNY | 40.77亿 CNY | 31.96亿 CNY | 23.15亿 CNY |
| 销货成本 | 29.85亿 CNY | 31.17亿 CNY | 28.1亿 CNY | 21.79亿 CNY | 15.71亿 CNY |
| 毛利 | 10.23亿 CNY | 13.29亿 CNY | 12.67亿 CNY | 10.17亿 CNY | 7.45亿 CNY |
| 研究与开发 | 1004.6万 CNY | 1323.7万 CNY | — | — | — |
| 销售、一般及管理费用 | 4.7亿 CNY | 4.91亿 CNY | 4.13亿 CNY | 2.93亿 CNY | 2.25亿 CNY |
| 营业费用 | 6.3亿 CNY | 5.08亿 CNY | 3.78亿 CNY | 3.5亿 CNY | 1.51亿 CNY |
| 利息收入 | 325.5万 CNY | 151.4万 CNY | 1015.3万 CNY | 1731.8万 CNY | 215.5万 CNY |
| 利息支出 | 6914.7万 CNY | 7184.2万 CNY | 4317万 CNY | 3488.1万 CNY | 2308.5万 CNY |
| 折旧和摊销 | 3.04亿 CNY | 2.95亿 CNY | 2.11亿 CNY | 1.53亿 CNY | 1.14亿 CNY |
| 营业利润 | 3.93亿 CNY | 8.21亿 CNY | 8.89亿 CNY | 6.67亿 CNY | 5.94亿 CNY |
| 净利润 | 1.65亿 CNY | 5.98亿 CNY | 6.83亿 CNY | 4.77亿 CNY | 4.41亿 CNY |
公司数据更新于 2026年10月10日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
HK$0.1636
2023年（完整年度）+13.6% 自从 2021
HK$0.1441
2,021
HK$0.1636
2,023
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2023年6月30日 | HK$0.1636Irregular | 2023年7月3日 | 2023年7月27日 |
股息 | 2021年6月30日 | HK$0.1441Irregular | 2021年7月5日 | 2021年7月26日 |
除息 2023年6月30日
HK$0.1636
Irregular
2023年7月3日登记 · 支付日 2023年7月27日
除息 2021年6月30日
HK$0.1441
Irregular
2021年7月5日登记 · 支付日 2021年7月26日
报告持有此股票敞口的交易所交易基金。
Vanguard Total International Stock ETFVXUS644.39万0.00%6657亿 USD0.05%US$84.82+0.86%
iShares Core MSCI Emerging Markets ETFIEMG601.1万0.00%1589.63亿 USD0.09%US$81.40+1.12%
Vanguard FTSE Emerging Markets ETFVWO594.69万0.00%1685亿 USD0.06%US$59.76+1.12%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS225.78万0.01%145亿 USD0.06%US$155.12+0.98%
iShares Core MSCI Total International Stock ETFIXUS138.43万0.00%582.06亿 USD0.07%US$94.99+0.90%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM83.58万0.01%96.67亿 USD0.39%US$40.01+1.07%
State Street SPDR Portfolio Emerging Markets ETFSPEM63.31万0.00%175.23亿 USD0.07%US$52.21+1.32%
Avantis Emerging Markets Equity ETFAVEM50.71万—281.73亿 USD0.33%US$94.11+0.93%Vanguard Total International Stock ETFVXUSiShares Core MSCI Emerging Markets ETFIEMGVanguard FTSE Emerging Markets ETFVWOVanguard FTSE All-World ex-US Small-Cap ETFVSSiShares Core MSCI Total International Stock ETFIXUSDimensional - Emerging Markets Core Equity 2 ETFDFEMState Street SPDR Portfolio Emerging Markets ETFSPEMAvantis Emerging Markets Equity ETFAVEMAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
